Presentation TCT 2017 First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease Presenter: Daniel Burkhoff, Samir R. Kapadia, Alaide Chieffo November 01, 2017
Presentation TCT 2017 Pressure-controlled Intermittent Coronary Sinus Occlusion Reduces Infarct Size After Primary PCI: A Propensity-controlled Matched Study Presenter: Dariusz Dudek, Cindy L. Grines, Azfar G. Zaman November 01, 2017
News Industry News Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology August 15, 2017
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017
News Industry News Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year May 18, 2017
News Industry News Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes May 02, 2017
News Daily News Oktoberfest Revelers Show That Drinking Alcohol Gets the Heart Racing Todd Neale April 26, 2017
News Conference News ACC 2017 Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports Michael O'Riordan March 24, 2017
Presentation JIM 2017 The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina Presenter: Francesco Giannini February 10, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2017 Caitlin E. Cox February 01, 2017
News Daily News Aspirate Contrast to Limit Acute Kidney Injury in Select Coronary Angiography Cases: Maybe, Maybe Not Yael L. Maxwell January 09, 2017
Presentation Efficacy and Safety of Coronary Sinus Aspiration During Coronary Angiography to Attenuate the Risk of Contrast-Induced AKI in Predisposed Patients Presenter: Osama Ali Diab January 09, 2017
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017
News Industry News Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation December 01, 2016
Presentation TCT 2016 When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gregg W. Stone October 31, 2016
Presentation TCT 2016 Indirect Annuloplasty via the Coronary Sinus II: Mitral Cerclage Presenter: Ted Feldman, Scott Lim, Robert J. Lederman October 31, 2016
Presentation TCT 2016 Indirect Annuloplasty via the Coronary Sinus II: MVRx Presenter: Ted Feldman, Scott Lim, David Hildick-Smith October 31, 2016
Presentation TCT 2016 Indirect Annuloplasty via the Coronary Sinus I: Updated Carillon Results and Future Plans Presenter: Ted Feldman, Scott Lim, Samir R. Kapadia October 31, 2016
Presentation TCT 2016 TCT 606: Can we justify conservative treatment in adults with Anomalous Coronary Artery Originating from the Opposite Sinus of Valsalva (ACAOS) with Inter-Arterial Course (IAC)? Presenter: Theodore A. Bass, Jan J. Piek October 31, 2016
Presentation TCT 2016 Rationale and Studies of P2Y12 Inhibitor Monotherapy After DES In Patients In Normal Sinus Rhythm Presenter: John A. Bittl, Daniel I. Simon, Patrick W. Serruys October 30, 2016